You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Novel Extended-Zone High Power WDM Couplers

    SBC: Q-PEAK INCORPORATED            Topic: AF13AT03

    ABSTRACT: High power and low insertion loss WDM components will be developed. In manufacturing WDM components, solid core fibers in both polarization insensitive and polarization maintaining, will be pursued, along with photonics crystal fiber components. A range of fiber sizes and device specifications will be developed and commercially offered by Q-Peak. The component that we propose to develo ...

    STTR Phase I 2014 Department of DefenseAir Force
  2. Novel Sacrificial Fibers for Microvascular Composites with Embedded Thermal Management Devices

    SBC: AURORA FLIGHT SCIENCES CORPORATION            Topic: AF13AT09

    ABSTRACT: Aurora will demonstrate on our automated fiber placement (AFP) machine that we are able to lay up composite panels that contain sacrificial fibers that can be thermally decomposed to create a microvascular network of small cavities that allow the panel to act as a heat exchanger. The AFP machine is capable of producing composite parts from mold tools as large as 9"high by 18"wide by 56 ...

    STTR Phase I 2014 Department of DefenseAir Force
  3. Representation and Inference for Developing Deep Language Engines (RIDDLE)

    SBC: Charles River Analytics, Inc.            Topic: AF13AT11

    ABSTRACT: Intelligence analysts need to process large amounts of text information to form an understanding of a topic of interest. The sheer amount of information can be overwhelming, so automated text analytics that assist with filtering, information extraction, and document understanding, can be highly beneficial. Deep natural language processing (NLP) applications require both structural knowl ...

    STTR Phase I 2014 Department of DefenseAir Force
  4. GUARD: General Utility for Assessing Risk of Disclosure

    SBC: Aptima, Inc.            Topic: AF13AT14

    ABSTRACT: Information is a national asset that must be protected. To make effective use of this asset, information sharing is critical between government agencies, with foreign government partners, and with the private sector. At the same time, in practice, balancing information sharing and information protection can be difficult. Tools are needed to address many challenges, including managing ...

    STTR Phase I 2014 Department of DefenseAir Force
  5. Compact CMOS-Compatible Optical Transceiver

    SBC: Physical Sciences Inc.            Topic: AF14AT13

    ABSTRACT: Close integration of photonic devices with silicon complementary metal-oxide semiconductor (CMOS) electronics can yield significant performance improvements in many applications. The recent development of novel integrated structures in silicon including waveguides, resonators, and photodetectors will enable dramatic reductions in size, weight, and power for components implementing compl ...

    STTR Phase I 2014 Department of DefenseAir Force
  6. Development of small near-infrared laser system capable of improving immune respo

    SBC: SEMINEX CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): The broad and long-term objective of this project is to amplify the effectiveness of vaccines without the use of chemical or biological adjuvants. We will address this objective by demonstrating the feasibility for small laser- based devices to enhance responses to intradermal vaccination. A number of investigators have shown that a promising new way to make va ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Therapeutic Utility of renalase and renalase peptides in cisplatin-mediated renal

    SBC: BESSOR PHARMA, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Cisplatin is a cornerstone therapy for a number of cancers including testicular, bladder, ovarian and lung. It is also used to treat cancers in children. In all cases there is a high incidence of acute kidney injury (AKI) that can also lead to later stage kidney damage. This risk limits its use. We have found in pilot studies that renalase, or peptide fragment ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. DNP Polarization Agents for Real-Time Metabolic Imaging and Clinical Diagnosis

    SBC: DYNUPOL, INC.            Topic: NCI

    Project Summary / Abstract Although standard MRI techniques provide valuable structural insight, a related technique known as magnetic resonance spectroscopy (MRS) adds powerful real-time metabolic information about the tissues under study. MRS provides early detection of disease, monitoring treatment efficacy, and, in the case of cancer, a dramatic reduction in unnecessary biopsies. However, bro ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Developing Inhibitors of the STARS/SRF Pathway for Treatment of Type 2 Diabetes

    SBC: Jenesis Biosciences LLC            Topic: NIDDK

    DESCRIPTION (provided by applicant): Type 2 diabetes (T2D) has reached epidemic proportions in the United States, affecting an estimated 8.3% of the population. Unfortunately, the majority of individuals with diabetes continue to have suboptimal control ofglucose, therefore new and improved approaches to prevention and treatment are sorely needed. Dr. Mary Elizabeth Patti's laboratory at the ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Novel commensal polysaccharide treats multiple sclerosis through Treg modulation

    SBC: SYMBIOTIX BIOTHERAPIES, INC.            Topic: NIAID

    Abstract Multiple sclerosis (MS) is a chronic demyelinating inflammatory disease that is the most common neurological disease of young adults, affecting over 350,000 patients in the US and over 2.5 million patients worldwide. MS is a disease of high unmetmedical need, currently treatable with one of several approved drugs, all of which result in either immune modulation or significant immunosuppre ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government